Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

詳細情報 詳細情報について

• CRID

  1363951795271844480

• DOI

  10.1016/j.ejca.2011.12.006

• ISSN

  09598049

• Web Site

  https://api.elsevier.com/content/article/PII:S0959804911010318?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0959804911010318?httpAccept=text/plain

• データソース種別

  • Crossref